Company · CIK 0001075880 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
KAZIA THERAPEUTICS LTD · KZIA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2026 AForm 4 → | Jun 23, 6:47 pm EDT | James E. LevineChief Financial Officer | 200,000 | — | — | 200,000 | — | |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:47 pm EDT | Sudha RaoChief Scientific Officer | 250,000 | — | — | 250,000 | — | |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:59 pm EDT | Steven R. S. CoffeyDirector | 100,000 | — | — | 100,000 | — | late |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:59 pm EDT | John E. Friend IIChief Executive Officer | 650,000 | — | — | 150,000 | — | late |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:58 pm EDT | Jeffrey BonacordaVP, Finance and Controller | 150,000 | — | — | 150,000 | — | late |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:58 pm EDT | Ebru DavidsonDirector | 100,000 | — | — | 100,000 | — | late |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:57 pm EDT | David CainDirector, CMC | 100,000 | — | — | 100,000 | — | late |
| Jan 8, 2026 AForm 4 → | Jul 8, 4:57 pm EDT | Robert F AppleDirector | 75,000 | — | — | 75,000 | — | late |